Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research.

Currently nitazoxanide is being assessed as a candidate therapeutic for SARS-CoV-2. Unlike many other candidates being investigated, tizoxanide (the active metabolite of nitazoxanide) plasma concentrations achieve antiviral levels after administration of the approved dose, although higher doses are...

Descripción completa

Detalles Bibliográficos
Autores principales: Neary, Megan, Arshad, Usman, Tatham, Lee, Pertinez, Henry, Box, Helen, Rajoli, Rajith KR, Valentijn, Anthony, Sharp, Joanne, Rannard, Steve P, Biagini, Giancarlo A, Curley, Paul, Owen, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168394/
https://www.ncbi.nlm.nih.gov/pubmed/34075381
http://dx.doi.org/10.1101/2021.05.27.445500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8168394/
https://www.ncbi.nlm.nih.gov/pubmed/34075381
http://dx.doi.org/10.1101/2021.05.27.445500

Ejemplares similares